Pharmacology
Pharmacology โ The science of drugs
Pharmacology is the branch of medicine and biology that studies drug action, including the sources, chemical properties, biological effects, and therapeutic uses of drugs.
๐ Key Fact: The global pharmaceutical market is worth over $1.8 trillion, with over 20,000 prescription drugs approved worldwide.
Drug Categories
| Category | Examples | Mechanism |
| Analgesics | Morphine, ibuprofen | Pain relief |
| Antibiotics | Penicillin, amoxicillin | Kill bacteria |
| Antivirals | Acyclovir, remdesivir | Inhibit viruses |
| Antihypertensives | Lisinopril, amlodipine | Lower blood pressure |
| Antidepressants | Fluoxetine, sertraline | Regulate serotonin |
| Antidiabetics | Metformin, insulin | Control blood sugar |
| Anticoagulants | Warfarin, heparin | Prevent blood clots |
| Immunosuppressants | Cyclosporine, tacrolimus | Suppress immune response |
Pharmacokinetics
- Absorption: How the drug enters the bloodstream
- Distribution: How the drug spreads through the body
- Metabolism: How the body breaks down the drug (liver)
- Excretion: How the body eliminates the drug (kidneys)
Key Pharmacological Concepts
- Potency: The amount of drug required to produce a specific effect
- Efficacy: The maximum effect a drug can produce
- Therapeutic Index: The safety margin (effective dose / toxic dose)
- Drug Interactions: Effects of one drug on another
- Half-life: Time for drug concentration to decrease by 50%
Drug Development Process
- Discovery: Identification of potential drug targets
- Preclinical: Laboratory and animal testing
- Phase I: Safety testing in healthy volunteers (20-80 participants)
- Phase II: Efficacy testing in patients (100-300 participants)
- Phase III: Large-scale efficacy and safety (1,000-3,000 participants)
- FDA Approval: Regulatory review and approval
- Phase IV: Post-marketing surveillance
Top 10 Best-Selling Drugs (2024)
| Rank | Drug | Brand Name | Annual Sales |
| 1 | Keytruda | Pembrolizumab | $25 Billion |
| 2 | Humira | Adalimumab | $21 Billion |
| 3 | Eliquis | Apixaban | $20 Billion |
| 4 | Dupixent | Dupilumab | $14 Billion |
| 5 | Biktarvy | Bictegravir/TAF/FTC | $12 Billion |
"The right drug for the right patient at the right time โ that's the promise of modern pharmacology." โ Dr. Janet Woodcock
FDA Commissioner